| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.054 | 0.2 |